We now review the potential kidney health implications of tirzepatide, addressing its structure and function, relationship to current GLP1 receptor agonists, impact of recent results for the treatment and prevention of kidney disease, and expectations for the future
Tirzepatide versus retatrutide: understanding the dose difference Retatrutide is the next-generation GLP-1 compound that adds a third receptor target to tirzepatide dual-agonist mechanism
Abdellatif A, Bahria K, Slama N, Oukrif D, Shalaby A, Birkmayer G, et al
Parkinsons disease Parkinsons disease (PD) is a long-term neurodegenerative disorder that affects the motor system, characterized primarily by the death of dopaminergic neurons in the substantia nigra and the presence of intracellular aggregates of misfolded -synucleine (Lewy bodies) in the surviving neurons 54,55